Literature DB >> 18492773

Aldosterone, but not angiotensin II, increases profibrotic factors in kidney of adrenalectomized stroke-prone spontaneously hypertensive rats.

Tae-Yon Chun1, Praveen N Chander, Jong-Won Kim, J Howard Pratt, Charles T Stier.   

Abstract

An increase in angiotensin II (ANG II) under conditions of high salt intake can result in renal damage. The extent to which ANG II does this directly or by way of stimulating aldosterone (Aldo) secretion is a subject of some debate. In the present study, we sought to determine the separate effects of Aldo and ANG II on the expression of plasminogen activator inhibitor-1 (PAI-1) and other factors related to renal fibrosis in the stroke-prone spontaneously hypertensive rat (SHRSP). Saline-drinking male SHRSPs underwent adrenalectomy (ADX) or sham operation (Sham). Treatment groups consisted of ADX + ANG II (25 ng/min sc) and ADX + Aldo (40 microg.kg(-1).day(-1) sc). After 2 wk of treatment, circulating Aldo levels were reduced to the limit of detection, renal PAI-1, transforming growth factor-beta1 (TGF-beta1), and osteopontin expression, and phospho-Smad2 (p-Smad2) level were decreased severalfold, and Smad7 (an inhibitory regulator of TGF-beta1 action) expression was increased in ADX compared with Sham rats. Infusion of Aldo into ADX SHRSPs restored the renal mRNA expression of PAI-1, TGF-beta1 (along with restored p-Smad2 level), and osteopontin and reduced that of Smad7, whereas ANG II had no or a lesser effect. The findings were confirmed by histological examination of renal tissue. In summary, in the saline-drinking SHRSP, Aldo increased renal profibrotic factors and produced renal injury whereas ANG II in the absence of the adrenals had no effect.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18492773      PMCID: PMC2519756          DOI: 10.1152/ajpendo.00512.2007

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  40 in total

Review 1.  Controlling TGF-beta signaling.

Authors:  J Massagué; Y G Chen
Journal:  Genes Dev       Date:  2000-03-15       Impact factor: 11.361

Review 2.  TGF-beta: from latent to active.

Authors:  N Khalil
Journal:  Microbes Infect       Date:  1999-12       Impact factor: 2.700

3.  Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation.

Authors:  Jin H Li; Hong-Jian Zhu; Xiao R Huang; Kar N Lai; Richard J Johnson; Hui Y Lan
Journal:  J Am Soc Nephrol       Date:  2002-06       Impact factor: 10.121

4.  Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin.

Authors:  N A Trueblood; Z Xie; C Communal; F Sam; S Ngoy; L Liaw; A W Jenkins; J Wang; D B Sawyer; O H Bing; C S Apstein; W S Colucci; K Singh
Journal:  Circ Res       Date:  2001-05-25       Impact factor: 17.367

5.  Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo.

Authors:  N J Brown; S Nakamura; L Ma; I Nakamura; E Donnert; M Freeman; D E Vaughan; A B Fogo
Journal:  Kidney Int       Date:  2000-09       Impact factor: 10.612

6.  Mechanisms of inactivation of the action of aldosterone on collecting duct by TGF-beta.

Authors:  R F Husted; R D Sigmund; J B Stokes
Journal:  Am J Physiol Renal Physiol       Date:  2000-03

7.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

Authors:  B M Brenner; M E Cooper; D de Zeeuw; W F Keane; W E Mitch; H H Parving; G Remuzzi; S M Snapinn; Z Zhang; S Shahinfar
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

Review 8.  Plasmin and matrix metalloproteinases in vascular remodeling.

Authors:  H R Lijnen
Journal:  Thromb Haemost       Date:  2001-07       Impact factor: 5.249

9.  Local angiotensin II and transforming growth factor-beta1 in renal fibrosis of rats.

Authors:  Y Sun; J Zhang; J Q Zhang; F J Ramires
Journal:  Hypertension       Date:  2000-05       Impact factor: 10.190

10.  Spironolactone abolishes the relationship between aldosterone and plasminogen activator inhibitor-1 in humans.

Authors:  Pairunyar Sawathiparnich; Sandeep Kumar; Douglas E Vaughan; Nancy J Brown
Journal:  J Clin Endocrinol Metab       Date:  2002-02       Impact factor: 5.958

View more
  6 in total

1.  Variations in the potassium channel genes KCNK3 and KCNK9 in relation to blood pressure and aldosterone production: an exploratory study.

Authors:  Jeesun Jung; Paula Q Barrett; George J Eckert; Howard J Edenberg; Xiaoling Xuei; Wanzhu Tu; J Howard Pratt
Journal:  J Clin Endocrinol Metab       Date:  2012-08-14       Impact factor: 5.958

Review 2.  Aldosterone: effects on the kidney and cardiovascular system.

Authors:  Marie Briet; Ernesto L Schiffrin
Journal:  Nat Rev Nephrol       Date:  2010-03-16       Impact factor: 28.314

3.  Aldosterone and TGF-β₁ synergistically increase PAI-1 expression in hepatic stellate cells of rats.

Authors:  Sheng-Lan Wang; Hui-Min Wu; Cheng-Zhi He; Li Yang; Heng-Jun Gao; Chang-Qing Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 4.  Chronic kidney disease: a new look at pathogenetic mechanisms and treatment options.

Authors:  Damien Noone; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2013-03-08       Impact factor: 3.714

5.  Role of mineralocorticoid receptor/Rho/Rho-kinase pathway in obesity-related renal injury.

Authors:  H Tokuyama; S Wakino; Y Hara; N Washida; K Fujimura; K Hosoya; K Yoshioka; K Hasegawa; H Minakuchi; K Homma; K Hayashi; H Itoh
Journal:  Int J Obes (Lond)       Date:  2011-12-20       Impact factor: 5.095

6.  Aldosterone induces NRK-52E cell apoptosis in acute kidney injury via rno-miR-203 hypermethylation and Kim-1 upregulation.

Authors:  Xiangcheng Xiao; Rong Tang; Xiao Zhou; Ling Peng; Pingping Yu
Journal:  Exp Ther Med       Date:  2016-06-08       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.